Klara Dickinson-Eason

2016

In 2016, Klara Dickinson-Eason earned a total compensation of $705.5K as SVP, Chief Regulatory Office at Anthera Pharmaceuticals, a 28% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$85,386
Option Awards$287,661
Salary$332,500
Total$705,547

Dickinson-Eason received $332.5K in salary, accounting for 47% of the total pay in 2016.

Dickinson-Eason also received $85.4K in non-equity incentive plan and $287.7K in option awards.

Rankings

In 2016, Klara Dickinson-Eason's compensation ranked 9,841st out of 14,075 executives tracked by ExecPay. In other words, Dickinson-Eason earned more than 30.1% of executives.

ClassificationRankingPercentile
All
9,841
out of 14,075
30th
Division
Manufacturing
3,802
out of 5,489
31st
Major group
Chemicals And Allied Products
1,331
out of 1,895
30th
Industry group
Drugs
1,059
out of 1,538
31st
Industry
Pharmaceutical Preparations
832
out of 1,176
29th
Source: SEC filing on March 16, 2017.

Dickinson-Eason's colleagues

We found five more compensation records of executives who worked with Klara Dickinson-Eason at Anthera Pharmaceuticals in 2016.

2016

Craig Thompson

Anthera Pharmaceuticals

Chief Executive Officer

2016

Paul Truex

Anthera Pharmaceuticals

Chief Executive Officer

2016

William Shanahan

Anthera Pharmaceuticals

Chief Medical Officer

2016

Chuck Olson

Anthera Pharmaceuticals

Chief Technology Officer

2016

May Liu

Anthera Pharmaceuticals

SVP, Finance & Administration

You may also like